- Home
- PRGO vs HHH Comparison
PRGO vs HHH Comparison
Compare PRGO & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- HHH
- Stock Information
- Founded
- PRGO 1887
- HHH 2010
- Country
- PRGO Ireland
- HHH United States
- Employees
- PRGO N/A
- HHH N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- PRGO Health Care
- HHH Real Estate
- Exchange
- PRGO Nasdaq
- HHH Nasdaq
- Market Cap
- PRGO 3.7B
- HHH 3.3B
- IPO Year
- PRGO 1991
- HHH N/A
- Fundamental
- Price
- PRGO $27.04
- HHH $69.26
- Analyst Decision
- PRGO Buy
- HHH Buy
- Analyst Count
- PRGO 3
- HHH 2
- Target Price
- PRGO $33.00
- HHH $80.50
- AVG Volume (30 Days)
- PRGO 936.3K
- HHH 492.2K
- Earning Date
- PRGO 08-01-2025
- HHH 08-06-2025
- Dividend Yield
- PRGO 4.27%
- HHH N/A
- EPS Growth
- PRGO N/A
- HHH N/A
- EPS
- PRGO N/A
- HHH 5.22
- Revenue
- PRGO $4,335,200,000.00
- HHH $1,793,533,000.00
- Revenue This Year
- PRGO $3.24
- HHH N/A
- Revenue Next Year
- PRGO $2.15
- HHH $24.62
- P/E Ratio
- PRGO N/A
- HHH $13.23
- Revenue Growth
- PRGO N/A
- HHH 106.40
- 52 Week Low
- PRGO $23.14
- HHH $59.83
- 52 Week High
- PRGO $30.93
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- PRGO 51.80
- HHH 56.11
- Support Level
- PRGO $26.85
- HHH $68.15
- Resistance Level
- PRGO $27.48
- HHH $71.59
- Average True Range (ATR)
- PRGO 0.65
- HHH 1.37
- MACD
- PRGO 0.03
- HHH 0.27
- Stochastic Oscillator
- PRGO 45.28
- HHH 78.96
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.